Ads
related to: german cancer research center heidelberg
Search results
Results from the WOW.Com Content Network
The German Cancer Research Center (known as the Deutsches Krebsforschungszentrum or simply DKFZ in German) is a national cancer research center based in Heidelberg, Germany. It is a member of the Helmholtz Association of German Research Centres , the largest scientific organization in Germany.
Over 1 million patients per year are treated at the University Hospital Heidelberg. [5] The hospital is especially renowned for the treatment of cancer.A recent innovation in the care of cancer patient is the foundation of the National Center of Tumor Diseases (NCT) in cooperation with German Cancer Research Center (DKFZ). [6]
Following completion of his doctorate (Heidelberg) and habilitation he became a university professor in Heidelberg and, at the same time, became the head of a department at the German Cancer Research Center. [1] In 1982, Franke became the president of the European Cell Biology Organization (ECBO), a post he held until 1990. [1]
Magnus von Knebel Doeberitz is a molecular oncologist and virologist, a professor of molecular oncology and medical director of the Department of Applied Tumor Biology at the Institute of Pathology at the University Hospital of Heidelberg. He also heads a Clinical Cooperation at the German Cancer Research Center. [1]
Peter Heinrich Krammer (born in 1946) is a German immunologist and one of the directors of The National Center for Tumor Diseases (NCT), [1] as well as the head of the Division Immunogenetics [2] at the German Cancer Research Center (DKFZ) in Heidelberg. Peter H. Krammer is well known for his research and findings in apoptosis.
The Meyenburg Prize is awarded for outstanding achievements in cancer research by the Meyenburg Foundation in support of the German Cancer Research Center, Heidelberg (DKFZ), which is the largest biomedical research institution in Germany. The prize has been awarded annually since 1981, and currently has an honorarium of €50,000.
A company called Tomorrow Biostasis is focusing on human cryopreservation in the hopes it can eventually reverse death.. The new Berlin startup has already preserved the bodies of about 10 ...
Baumert studied medicine at the Freiburg and Heidelberg universities, the University of Chicago, and at the Baylor College of Medicine.On completing a doctoral thesis at the German Cancer Research Center (DKFZ) in Heidelberg, and a medicine internship at the Ludwig Maximilians University (LMU) in Munich, Baumert received his MD degree from the Heidelberg University.
Ads
related to: german cancer research center heidelberg